TAKING PATIENT HETEROGENEITY AND PREFERENCES INTO ACCOUNT IN HEALTH TECHNOLOGY ASSESSMENTS
- PMID: 29065947
- DOI: 10.1017/S0266462317000885
TAKING PATIENT HETEROGENEITY AND PREFERENCES INTO ACCOUNT IN HEALTH TECHNOLOGY ASSESSMENTS
Abstract
Objectives: The INTEGRATE-HTA project provided methodology to evaluate complex technologies. This study provides guidance on how to retrieve and critically appraise available evidence on moderators and predictors of treatment effects and on patient preferences for treatment outcomes as a source of complexity.
Methods: Search filters for PubMed were developed by hand-searching a large volume of articles reporting on relevant aspects. Search terms were retrieved from selected papers and algorithmically combined to find the optimal combination of search terms. For the development of the appraisal checklists literature was searched in PubMed and Google Scholar together with citation chasing. For the CHecklist for the Appraisal of Moderators and Predictors (CHAMP) a Delphi procedure was used to value a set of eligible appraisal criteria retrieved from the literature.
Results: Search filters were developed optimized for different accuracy measures. The final version of CHAMP consists of a seventeen questions covering the design, analysis, results and transferability of results of moderator and predictor analysis. The final checklist for appraisal of literature on patient preferences for treatment outcomes consist of six questions meant to help the user to identify relevant quality issues together with a guidance toward existing tools concerning the appraisal of specific preference elicitation methods.
Conclusions: Incorporating knowledge on subgroups for whom a specific treatment will produce more benefit holds the promise of better targeting and, ultimately, enhancing overall effectiveness and efficiency of healthcare technology. Finally, incorporating information on preferences for treatment outcomes will foster health technology assessment that addresses outcomes that are important to patients.
Keywords: Complex interventions; Health technology assessment; INTEGRATE-HTA; Moderators; Patient preferences; Predictors.
Similar articles
-
The development of CHAMP: a checklist for the appraisal of moderators and predictors.BMC Med Res Methodol. 2017 Dec 21;17(1):173. doi: 10.1186/s12874-017-0451-0. BMC Med Res Methodol. 2017. PMID: 29268721 Free PMC article.
-
COMPREHENSIVE ASSESSMENT OF COMPLEX TECHNOLOGIES: INTEGRATING VARIOUS ASPECTS IN HEALTH TECHNOLOGY ASSESSMENT.Int J Technol Assess Health Care. 2017 Jan;33(5):570-576. doi: 10.1017/S0266462317000678. Epub 2017 Aug 7. Int J Technol Assess Health Care. 2017. PMID: 28780928
-
AN INTEGRATED PERSPECTIVE ON THE ASSESSMENT OF TECHNOLOGIES: INTEGRATE-HTA.Int J Technol Assess Health Care. 2017 Jan;33(5):544-551. doi: 10.1017/S0266462317000484. Epub 2017 Jul 31. Int J Technol Assess Health Care. 2017. PMID: 28756780
-
INTEGRATE-HTA: A LOW- AND MIDDLE-INCOME COUNTRY PERSPECTIVE.Int J Technol Assess Health Care. 2017 Jan;33(5):599-604. doi: 10.1017/S0266462317000927. Epub 2017 Nov 6. Int J Technol Assess Health Care. 2017. PMID: 29103380 Review.
-
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India.Appl Health Econ Health Policy. 2023 Jan;21(1):11-22. doi: 10.1007/s40258-022-00766-5. Epub 2022 Oct 19. Appl Health Econ Health Policy. 2023. PMID: 36260276 Free PMC article. Review.
Cited by
-
A discrete choice experiment on preferences of patients with low back pain about non-surgical treatments: identification, refinement and selection of attributes and levels.Patient Prefer Adherence. 2019 Jun 12;13:933-940. doi: 10.2147/PPA.S201401. eCollection 2019. Patient Prefer Adherence. 2019. PMID: 31354247 Free PMC article.
-
Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study.Front Pharmacol. 2019 Dec 3;10:1395. doi: 10.3389/fphar.2019.01395. eCollection 2019. Front Pharmacol. 2019. PMID: 31849657 Free PMC article.
-
Examining patient and professional perspectives in the UK for gene therapy in haemophilia.Haemophilia. 2022 Jul;28(4):588-609. doi: 10.1111/hae.14572. Epub 2022 Apr 19. Haemophilia. 2022. PMID: 35438818 Free PMC article.
-
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US.Front Pharmacol. 2019 Sep 18;10:1009. doi: 10.3389/fphar.2019.01009. eCollection 2019. Front Pharmacol. 2019. PMID: 31619989 Free PMC article.
-
Complexity and function of family involvement in advance care planning: A qualitative study of perspectives from people living with advanced cancer, family members and healthcare professionals.Palliat Med. 2023 Oct;37(9):1434-1446. doi: 10.1177/02692163231194202. Epub 2023 Sep 18. Palliat Med. 2023. PMID: 37723885 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources